Capricor Therapeutics | CAPR - Current Assets


Capricor Therapeutics reported $322.94M in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Alterity Therapeutics Limited AUD 37.91M 15.92M Dec/2025
Bioline Rx USD 28.52M 3.34M Sep/2025
Capricor Therapeutics USD 322.94M 221.99M Dec/2025
Cipla INR 249.18B 16.3B Sep/2025
Cytokinetics USD 916.97M 60.37M Dec/2025
Geron USD 520.27M 2.07M Dec/2025
Grifols EUR 5.96B 316.31M Dec/2025
Immunic USD 39.27M 20.57M Sep/2025
J&J USD 55.62B 1.01B Dec/2025
Plus Therapeutics USD 15.17M 2.42M Dec/2025
Prothena USD 315.19M 24.78M Dec/2025
PTC Therapeutics USD 2.27B 266.14M Dec/2025
Sarepta Therapeutics USD 2.54B 184.37M Dec/2025